Management of acute severe ulcerative colitis

scientific article

Management of acute severe ulcerative colitis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.4291/WJGP.V5.I4.579
P932PMC publication ID4231522
P698PubMed publication ID25401001
P5875ResearchGate publication ID268451489

P2093author name stringVineet Ahuja
Saurabh Kedia
Rakesh Tandon
P2860cites workOutcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in IndiaQ25256972
Risk factors for inflammatory bowel disease in the general populationQ28186843
Cyclosporine in severe ulcerative colitis refractory to steroid therapyQ34060783
Small bowel gas in severe ulcerative colitisQ34395164
Predicting outcome in severe ulcerative colitisQ34409849
THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.Q34478028
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-upQ34506976
Controlled trial of bowel rest in the treatment of severe acute colitisQ34529542
Cytomegalovirus colitis complicating inflammatory bowel diseaseQ34572006
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesQ34710712
A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and managementQ35593024
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitisQ35768942
Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studiesQ36145711
Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regressionQ36671830
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitisQ36720362
Adverse events associated with the use of cyclosporine in patients with inflammatory bowel diseaseQ37051414
Clostridium difficile and inflammatory bowel diseaseQ37165470
Surgery in ulcerative colitis: indication and timingQ37604764
Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel diseaseQ37868657
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitisQ40323292
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of GastroenterologyQ40390478
Intravenous cyclosporin in ulcerative colitis: a five-year experienceQ41671378
Assessment of severity in colitis: a preliminary studyQ41988487
Infliximab in severe steroid-refractory ulcerative colitis: a pilot study.Q42668130
Delayed surgery for acute severe colitis is associated with increased risk of postoperative complicationsQ43184169
Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy.Q43327810
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitisQ43582796
Outcome of cytomegalovirus infections in patients with inflammatory bowel diseaseQ43684194
A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitisQ43719249
Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohortQ44071902
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort studyQ44355973
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel diseaseQ44446912
Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitisQ44535154
Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgeryQ44607322
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximabQ44742543
Ciclosporin use in acute ulcerative colitis: a long-term experienceQ45221934
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.Q46130626
Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitisQ46152475
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.Q46531976
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitisQ46990369
Cortisone in ulcerative colitis; preliminary report on a therapeutic trialQ50417466
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.Q53122367
Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications.Q53741447
Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis.Q54115144
Intensive intravenous regimen for severe attacks of ulcerative colitis.Q54394687
Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery.Q54563945
Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.Q54568296
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial manQ57265461
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trialQ59120396
Impact of Hospital Volume on Postoperative Morbidity and Mortality Following a Colectomy for Ulcerative ColitisQ59563688
Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitisQ70539279
Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitisQ71133025
Colonoscopy of acute colitis. A safe and reliable tool for assessment of severityQ72048490
Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitisQ72688420
Subtotal colectomy for severe acute colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policyQ73880953
Management of acute severe colitisQ79922499
Female infertility after ileal pouch-anal anastomosis for ulcerative colitisQ80136298
Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitisQ80269736
Severe acute colitis associated with CMV: a prevalence studyQ81261144
Urgent subtotal colectomy for severe inflammatory bowel diseaseQ81360173
Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomyQ81416000
Simple score to identify colectomy risk in ulcerative colitis hospitalizationsQ82599194
ULCERATIVE COLITIS: A SURVEY OF NINETY-FIVE CASESQ84929815
P433issue4
P304page(s)579-588
P577publication date2014-11-01
P1433published inWorld journal of gastrointestinal pathophysiologyQ27723538
P1476titleManagement of acute severe ulcerative colitis.
P478volume5

Reverse relations

cites work (P2860)
Q52346955Chinese research into severe ulcerative colitis has increased in quantity and complexity.
Q34454060Evaluation of dairy allergy among ulcerative colitis patients.
Q88619085Healthy hosts rule within: ecological forces shaping the gut microbiota
Q47652740Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids
Q89047085Salvage therapy for acute severe ulcerative colitis during pregnancy
Q88677985Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients
Q38575522Surgical and medical treatment in patients with acute severe ulcerative colitis
Q61821109Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
Q28073443Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new?

Search more.